STOCK TITAN

Certara to Participate in the Barclays Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the Barclays Global Healthcare Conference.

Company management will present at 11:15AM ET on Wednesday, March 15th, 2023.

A live webcast of the event will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.

About Certara
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries.

Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com

Media Contact:
Daniel Yunger
Kekst CNC
daniel.yunger@kekstcnc.com


FAQ

When will Certara present at the Barclays Global Healthcare Conference?

Certara will present at the Barclays Global Healthcare Conference on March 15, 2023, at 11:15 AM ET.

Where can I watch Certara's presentation at the Barclays Conference?

You can watch Certara's presentation live on their investor relations website.

How long will the webcast of Certara's presentation be available?

The webcast of Certara's presentation will be available for replay for at least 90 days.

What industry does Certara operate in?

Certara operates in the biosimulation industry, focusing on drug discovery and development.

How many clients does Certara serve?

Certara serves over 2,000 clients globally.
Certara, Inc.

NASDAQ:CERT

CERT Rankings

CERT Latest News

CERT Stock Data

2.28B
121.01M
2.27%
96.57%
3.34%
Health Information Services
Services-prepackaged Software
Link
United States
RADNOR